Infectious Disease Companies

63 companies | Viral, bacterial, and parasitic infections

#	COMPANY	TYPE	STAGE
1.	ACESO (Austere environments Consortium for Enhanced Sepsis Outcomes) Silver Spring, MD, USA	Diagnostics	Phase 2	VIEW
2.	Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA)	Biotech	Clinical	VIEW
3.	Aldevron Fargo, USA	CDMO	Commercial	VIEW
4.	All India Institute of Medical Sciences, Raipur Raipur, India	Diagnostics	Commercial	VIEW
5.	Anthem Biosciences Bangalore, India	CDMO	Commercial	VIEW
6.	Astellas Pharma Inc. Tokyo, Japan	Pharma	Discovery to Phase 3	VIEW
7.	Becton Dickinson Franklin Lakes, New Jersey, USA	MedTech	Commercial	VIEW
8.	BenevolentAI London, United Kingdom	Biotech	Phase 1\|Phase 2\|Preclinical	VIEW
9.	BioMed Valley Discoveries Kansas City, Missouri, USA	Biotech	Clinical (Phase 1-2)	VIEW
10.	Boston Institute of Biotechnology Southborough, USA	CDMO	Commercial	VIEW
11.	CECOS University of Information Technology and Emerging Sciences Peshawar, Pakistan	Biotech	Preclinical	VIEW
12.	CERNO Eeklo (Ghent region), Belgium	CRO	Commercial	VIEW
13.	CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland	Biotech	Phase 3	VIEW
14.	Cadence Design Systems San Jose, USA	Digital Health	Commercial	VIEW
15.	Capgemini Paris, France	Digital Health	Commercial	VIEW
16.	Carelon Research Wilmington, Delaware, USA	CRO	Commercial	VIEW
17.	Cartel Health Care Private Limited Raipur, India	MedTech	Commercial	VIEW
18.	Celltrion Incheon, South Korea	Pharma	Commercial	VIEW
19.	Cerebras Systems Sunnyvale, USA	Digital Health	Commercial	VIEW
20.	Chiba University Chiba, Japan	Biotech	Phase 2	VIEW
21.	China Medical University Hospital (CMUH) Taichung, Taiwan	Biotech	Phase 2	VIEW
22.	Chung-Ang University Seoul, South Korea	Biotech	Phase 3	VIEW
23.	Cincinnati Children's Hospital Medical Center Cincinnati, USA	Biotech	Commercial	VIEW
24.	Cliantha Research Ahmedabad, India	CRO	Commercial	VIEW
25.	Constructor Group Schaffhausen, Switzerland	Biotech	Preclinical	VIEW
26.	Curative Biotechnology Inc Boca Raton, Florida, USA	Biotech	Pre-Clinical\|IND-Enabling Studies	VIEW
27.	Cytel Cambridge, MA, USA	CRO	Service Provider	VIEW
28.	CytoAgents Pittsburgh, USA	Biotech	Phase 2	VIEW
29.	Cytocom, Inc. Fort Collins, Colorado, USA	Biotech	Phase 2/Phase 3	VIEW
30.	Cytonus Therapeutics Carlsbad, California, United States	Biotech	Phase 1	VIEW
31.	Cytorex Biosciences Weston, Florida, USA	Biotech	Preclinical	VIEW
32.	ECRIN Paris, France	CRO	Commercial	VIEW
33.	Farmindustria Rome, Italy	Pharma	Commercial	VIEW
34.	Florence Healthcare Atlanta, USA	Digital Health	Commercial	VIEW
35.	Fusion Antibodies Belfast, Northern Ireland, United Kingdom	CRO	Discovery\|Preclinical\|Clinical (clients' projects)	VIEW
36.	GSK plc London, United Kingdom	Pharma	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
37.	Galpha Laboratories Limited Mumbai, India	Biotech	Commercial	VIEW
38.	HBM Partners Zug, Switzerland	Biotech	Commercial	VIEW
39.	ICLOS-PDLC L'Hospitalet de Llobregat (Barcelona), Spain	CRO	N/A (Service Provider)	VIEW
40.	Immunomic Therapeutics, Inc. Rockville, Maryland, United States	Biotech	Phase 1 - Phase 2	VIEW
41.	International Livestock Research Institute (ILRI) Nairobi, Kenya	Biotech	Commercial	VIEW
42.	Inttl Advocare New Delhi, India	CRO	Commercial	VIEW
43.	JOINN Laboratories Beijing, China	CRO	Commercial	VIEW
44.	Johnson & Johnson New Brunswick, New Jersey, USA	Pharma	Discovery\|Preclinical\|Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
45.	Life Science Strategy Group Menlo Park, USA	CRO	Commercial	VIEW
46.	Lifespan (now Brown University Health) Providence, USA	Pharma	Commercial	VIEW
47.	MSD Rahway, New Jersey, USA	Pharma	Commercial	VIEW
48.	Merck & Co., Inc. Rahway, New Jersey, United States	Pharma	Phase 1-Phase 3 and Commercial	VIEW
49.	NPDK Bioconsulting San Diego, California	CRO	Commercial	VIEW
50.	Parexel Raleigh, North Carolina, USA	CRO	Phase I-IV (as a CRO, Parexel manages client pipelines, not its own)	VIEW
51.	Pherecydes Pharma SA Romainville, France	Biotech	Phase 2	VIEW
52.	Roche Basel, Switzerland	Pharma	Discovery\|Preclinical\|Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
53.	SNIPR Biome Copenhagen, Denmark	Biotech	Phase 1b-2a	VIEW
54.	Sanofi Paris, France	Pharma	Preclinical through Phase 3	VIEW
55.	TechnoPhage Lisbon, Portugal	Biotech	Phase 1/IIa through Phase 3 in development	VIEW
56.	Thermo Fisher Scientific Waltham, Massachusetts, United States	CRO	Full spectrum - from drug discovery through Phase I-III and commercial	VIEW
57.	Universitas Indonesia Depok, Indonesia	CRO	Phase 3	VIEW
58.	University of British Columbia Vancouver, Canada	Biotech	Discovery	VIEW
59.	University of Colorado Boulder Boulder, USA	Biotech	Discovery	VIEW
60.	University of Wisconsin–Madison Madison, USA	Biotech	Commercial	VIEW
61.	Vaxcyte San Carlos, California, USA	Biotech	Clinical (Phase 2 and Phase 3)	VIEW
62.	Viatris Canonsburg, Pennsylvania, United States	Pharma	Phase 1 to Commercial	VIEW
63.	Zydus Lifesciences Limited Ahmedabad, India	Pharma	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW